Table 9.

Genotypes of the Apo E Gene and Parameters of the Lipid and Apolipoprotein Spectrum in the Kazakhs with Coronary Heart Disease (CHD)

Parameters (mmol/l)	E2E3	E3E3	E2E4	E3E4	E4E4
TC (mmol/l)	4.82±0.07	5.0 ±0.05	5.4±0.09*	5.7±0.06*	5.9±0.09*
HDLC	0.93±0.04	0.92±0.02	0.90±0.07	0.91±0.03	0.90±0.06
TG	2.2±0.06	2.1±0.07	2.3±0.10	2.4±0.08	2.3±0.15
LDLC	3.45±0.08	3.66±0.05	4.04±0.19*	4.31±0.07*	4.54±0.14*
VLDLPC	0.44±0.03	0.42±0.01	0.46±0.11	0.48±0.03	0.46±0.10
AI (relative unit)	4.18±0.18	4.43±0.13	5.0±0.26*	5.26±0.15*	5.56±0.22*
Apo A1 (mg/dl)	139.5± 3.6	138.6±2.3	138.4±4.3	137.9±3.2	136.3±5.5
Apo B (mg/dl)	104.1±3.8	105.1±2.4	103.1±4.4	100.2±2.9	101.9±4.2
Apo E (mg/dl)	6.6+0.32	6.8±0.25	6.4±0.48	6.3±0.28	6.2±0.40

^*p< 0,05